Clicky

Fluoropharma Medical Inc(FPMI)

Description: FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.


Keywords: Biopharmaceutical Imaging Cardiology Magnetic Resonance Imaging Circulatory System Cardiovascular System Coronary Artery Disease Molecular Imaging Cardiac Imaging

Home Page: www.fluoropharma.com

8 Hillside Avenue
Montclair, NJ 07042
United States
Phone: 973-744-1565


Officers

Name Title
Dr. Thomas H. Tulip Ph.D. CEO, Pres & Director
Ms. Tamara Rhein Chief Financial Officer
Mr. Edward L. Lyons Jr. VP of Devel.

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 17.7643
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 4
Back to stocks